 7. Women who are pregnant or breast feeding, or womenmen able to conceive and unwilling to practice an effective method of birth control throughout the trial and for 8 weeks after the last dose of study drug. Women of childbearing potential must have a negative pregnancy test. Oral, implantable, or injectable contraceptives may be affected by cytochrome P450 interactions, and are therefore not considered effective for this study. 